JQJuan Carlos Quintana

Juan Carlos Quintana

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Juan Carlos Quintana has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Intermediate‐Risk Papillary Thyroid Cancer: Not Everyone Needs Radioactive Iodine

    by Ignacio Fuentes, Marlín Solórzano, Annette Madison, Joel Falcón, Catalina Ruiz, Joaquín Viñambres, Rodolfo Cabello, Nicole Lustig, Lorena Mosso, Rodrigo Jaimovich, et al.

    Introduction: Intermediate‐risk papillary thyroid carcinoma (PTC) accounts for 40%–60% of newly diagnosed PTC and comprises a heterogeneous group with variable recurrence risk. The benefit of postoperative radioactive iodine (RAI) remains uncertain. Objectives: To describe features, response‐to‐therapy outcomes, and ATA 2025 recurrence‐risk redistribution in patients with ATA 2015 intermediate‐risk PTC managed without adjuvant RAI. Design: Retrospective cohort study. Methods: Adults (≥ 18 years) with ATA 2015 intermediate‐risk PTC treated with total thyroidectomy (TT) or thyroid lobectomy (TL), with/without lymph node dissection, and followed for ≥ 1 year were included. Omission of postoperative RAI was based on histopathology, cervical ultrasound (US), serum thyroglobulin (Tg), and anti‐thyroglobulin antibodies (TgAb) measured within 6 months postoperatively. TL patients required negative US. TT patients required negative US plus Tg < 1 ng/mL if TgAb‐negative, or stable/declining TgAb if positive. Response to therapy was assessed using ATA 2015 dynamic risk stratification and reassessed with ATA 2025 criteria. Results: Ninety‐nine patients were included; 84 (84.8%) were women, the mean age was 40.2 ± 13.3 years, and the median follow‐up was 4.8 years. Microscopic extrathyroidal extension was present in 51 (51.5%), lymph node metastases in 37 (37.4%), and extranodal extension in 4 (4.0%). By ATA 2015, 67 (67.7%) had an excellent response and 32 (32.3%) an indeterminate response; no incomplete responses or structural recurrences occurred. ATA 2025 reclassified 3 (3.0%) as low risk, 39 (39.4%) as low‐intermediate, 52 (52.5%) as high‐intermediate, and 5 (5.1%) as high risk. Conclusions: Selected intermediate‐risk PTC patients managed without adjuvant RAI had excellent mid‐term outcomes, supporting a risk‐adapted de‐escalation strategy.

  • Persistent elevated thyroglobulin revealing Struma ovarii in a patient treated for papillary thyroid carcinoma: A case report

    by Nicole Lustig, Leticia Rincón, Juan Carlos Quintana, Virginia Iturrieta, Ignacio Fuentes, Marlín Solórzano, Annette Madison, Lorena Mosso, Rodrigo Jaimovich, José Miguel Domínguez

  • Open Access

    Buenas prácticas para la publicación de imágenes radiológicas en revistas biomédicas: recomendaciones técnicas, éticas y guía paso a paso para autores

    by Joaquín Hevia-Morel, Álvaro Huete-Garín, Cecilia Besa-Correa, Carlos Quintana-Fresno

    Las imágenes radiológicas son esenciales en la comunicación científica biomédica, aportando evidencia visual para describir hallazgos, técnicas diagnósticas y discusiones clínicas. Sin embargo, su inclusión en manuscritos exige cumplir criterios técnicos, éticos y editoriales que garanticen calidad, reproducibilidad y confidencialidad. Este artículo revisa recomendaciones prácticas para autores, incluyendo aspectos técnicos de exportación y edición, estándares de calidad, consideraciones éticas y la importancia de la participación de especialistas en radiología. Se propone una guía paso a paso para la preparación de imágenes y pies de figura, orientada a facilitar la aceptación en revistas biomédicas y promover la estandarización en la publicación científica.

  • Effect of Low-Dose Statins in Addition to Standard Therapy on Brain Perfusion and Neurocognitive Performance in Patients with Major Depressive Disorder

    by Teresa Massardo, Juan C. Quintana, Luis Risco, Sebastian Corral, Jane Spuler, Daniel Vicentini, Gabriel Castro-Muñoz, Byron Riedel, Carolina Villa, Jaime I. Pereira

    Introduction: Major depressive disorder (MDD) is a prevalent condition which has a well-known association with ischemic cardiomyopathy, probably explained by an inflammatory mediator mechanism. Statins, besides reducing cholesterol production, have pleiotropic effects including anti-inflammatory activity. The goal was to evaluate the effect of statins as an addition to standard therapy on mood status, brain perfusion, and neurocognitive performance in MDD. Methods: We studied 20 MDD patients with brain single-photon emission tomography and Cambridge Neuropsychological Test Automated Battery (CANTAB), half randomized to 10 mg of Rosuvastatin or placebo, in addition to selective serotonin reuptake inhibitors (SSRIs) therapy and being reevaluated 3 months later. The images were compared using Statistical Parametric Mapping; clinical scores (Hamilton Depression Score with 17 items and Beck’s Depression Inventory) as well as neurocognitive parameters were applied as covariances (CoV) to estimate regional cerebral blood flow (rCBF) changes with both therapies. Results: Clinical scores decreased in both groups (p = 0.0001); Beck’s presented a larger decrease with statins. We observed significantly rCBF changes expressed as significant larger clusters of voxels (p < 0.05) in the pre/subgenual anterior cingulate plus orbitofrontal cortex and a small area in the posterior cingulate gyrus in the statins group, whereas it was not observed with placebo, when using clinical scores as CoV. A similar pattern of rCBF changes was present with emotions recognition, attentional, paired associates learning, spatial planning, and working memory tasks. Conclusion: Short-term use of low-dose statins in MDD patients under SSRIs results in important rCBF changes in key mood associated areas to improvement in neurocognitive performance. These findings, even though demonstrated in a small sample, could open a new therapeutic tool in the comprehensive management of this disorder.


  • Regional Brain Perfusion Is Associated with Endothelial Dysfunction Markers in Major Depressive Disorder

    by Teresa Massardo, Juan Carlos Quintana, Rodrigo Jaimovich, Claudia G. Sáez, Luis Risco, Claudio Liberman, Aída Verónica Araya, Tamara Galleguillos, Gabriel Castro-Mora, Jaime Pereira

    Background: Major depressive disorder (MDD) is an important independent risk factor for cardiovascular disease. Cumulative data suggest that depressive patients exhibit derangement in regional cerebral blood flow (rCBF), although underlying mechanisms remain mostly unknown. Endothelial dysfunction (ED), defined as different forms of abnormal endothelial activity, plays a key role in the pathogenesis of vascular disease. ED is associated with several clinical conditions characterized by high cardiovascular risk. Diverse ED markers have been found in mood disorders. Purpose: To evaluate the association between rCBF and peripheral ED markers in MDD patients, at baseline and after selective serotonin receptor inhibitors (SSRIs) therapy. Patients and Methods: Twenty-seven untreated unipolar MDD patients in their first episode were evaluated with the Hamilton Depression Rating Scale (HAM-D) and brain perfusion SPECT at baseline and after 2 months of SSRIs. Statistical Parametric Mapping (SPM) was employed to evaluate rCBF; circulating endothelial cells (CECs), plasma soluble intercellular adhesion molecule (sICAM), and high-sensitivity C-reactive protein (hsCRP) were used as independent covariates. Results: Baseline CECs and sICAM were increased in MDD patients compared with matching controls (p = 0.0001) and hsCRP (p = 0.03). HAM-D scores (21 items) and CECs diminished after SSRI therapy in MDD patients (p < 0.0001). There was a significant rCBF decrease, mainly in deep central structures. HAM-D change was associated with rCBF decrease at the left amygdala, right striatum levels, and Brodmann area 25. CEC change was associated with rCBF at deep brain level and sICAM with large rCBF areas at the left caudate and tectum; hsCRP was associated, to a lesser extent, with the left dorsal striatum and mesencephalic tectum. Conclusion: ED markers in patients with MDD are associated with significant changes in rCBF which are features of depression. These findings suggest that systemic damage/activation of the endothelium may contribute to the abnormal rCBF observed in MDD patients.